This Weight Loss Pill Could Increase Your Cancer Risk

As per a recent release, the drug lorcaserin (Belviq, Belviq XR) has reportedly been withdrawn by its manufacturing pharmaceutical company Eisai after a warning from the FDA stated that there’s a possibility that the drug could increase a person’s risk of cancer.
Read Original Article: This Weight Loss Pill Could Increase Your Cancer Risk »